Consultant clinical geneticist, honorary senior lecturer at King's College London
Shehla Mohammed is a full time NHS consultant and Paediatric clinical geneticist with 22 years’ experience predominantly in rare genetic disorders and in the care of children and families with life-limiting disorders.
As a previous Head of Service of the Guy’s Regional Genetics Service (1997-2017) she has extensive experience of negotiating the establishment of new services, implementing Highly Specialist Service clinics and devising novel models of service delivery
She represents the genetics speciality on local, regional and national committees working on national policy developments and research.
She is the national lead for CS/TTD Highly Specialist Service and the GSTT lead for National BBS Highly Specialist Service.
Education and training
Shehla Mohammed, graduated in Pakistan and undertook her postgraduate training in paediatrics and genetics in the U.K.
- MBBS, Fatima Jinnah Medical College, Lahore, Pakistan 1982
- MRCP, UK 1989
- MD, University of London, 1998
- FRCP, London 2003
- Clinical and research interests are in paediatric neuromuscular and DNA repair disorders
- Local PI for DDD study
- 1991 ICRF (Imperial Cancer Research Fund) Clinical Research Fellowship in Cancer Genetics: to investigate clinico-pathological and genetic basis of familial breast cancer (formed basis of MD study)
- 2010 Discovery Award 2010, Fanconi Anaemia Research Fund
- 2009 Shortlisted for UK Muslim Women's Power List
- Paediatric dysmorphology
- Premature aging syndromes
- Chromosome breakage disorders
- Paediatric neuromuscular diseases
- Expert Clinical Advisor to UK Genetic Testing Network
- Member of Highly Specialist Technology Committee of NICE
- Clinical advisor to the Cockayne Syndrome Support Group (“Amy and Friends”)
- Genetic Lead : London South-Sub speciality steering group UKCRN/NIHR
- Biomedical Research Centre (BRC) faculty member
A key focus on translational research, the implementation of robust technology platforms with the rapid translation of these into routine clinical diagnostic care aimed at delivering patient-focused, flexible, responsive and an integrated multidisciplinary genetics service.
Last updated: April 2022